These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 26534739)
1. Adjuvant chemotherapy in stage IB non-small cell lung carcinoma: A survival analysis. Coutinho D; Gonçalves A; Antunes A; Campainha S; Miranda J; Barroso A Rev Port Pneumol (2006); 2016; 22(2):123-5. PubMed ID: 26534739 [No Abstract] [Full Text] [Related]
2. Adjuvant treatment of stage IB NSCLC: the problem of stage subset heterogeneity. Calhoun R; Jablons D; Lau D; Gandara DR Oncology (Williston Park); 2008 Apr; 22(5):511-6; discussion 516, 521-3. PubMed ID: 18533401 [TBL] [Abstract][Full Text] [Related]
3. Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups. Strauss GM; Herndon JE; Maddaus MA; Johnstone DW; Johnson EA; Harpole DH; Gillenwater HH; Watson DM; Sugarbaker DJ; Schilsky RL; Vokes EE; Green MR J Clin Oncol; 2008 Nov; 26(31):5043-51. PubMed ID: 18809614 [TBL] [Abstract][Full Text] [Related]
14. A randomized Phase 2 study of pemetrexed in combination with cisplatin or carboplatin as adjuvant chemotherapy in patients with completely resected stage IB or II Non-Small-Cell Lung Cancer. Schmid-Bindert G; Engel-Riedel W; Reck M; Schuette W; Stöhlmacher J; Fischer JR; Mazières J; Chouaid C; Wolf M; Vinolas N; Soldatenkova V; Ripoche V; Nguyen T; Visseren-Grul C Lung Cancer; 2015 Dec; 90(3):397-404. PubMed ID: 26791798 [TBL] [Abstract][Full Text] [Related]
15. A retrospective comparison of adjuvant chemotherapeutic regimens for non-small cell lung cancer (NSCLC): paclitaxel plus carboplatin versus vinorelbine plus cisplatin. Chang WJ; Sun JM; Lee JY; Ahn JS; Ahn MJ; Park K Lung Cancer; 2014 Apr; 84(1):51-5. PubMed ID: 24521819 [TBL] [Abstract][Full Text] [Related]
16. Pathologic complete response to preoperative chemotherapy predicts cure in early-stage non-small-cell lung cancer: combined analysis of two IFCT randomized trials. Mouillet G; Monnet E; Milleron B; Puyraveau M; Quoix E; David P; Ducoloné A; Molinier O; Zalcman G; Depierre A; Westeel V; J Thorac Oncol; 2012 May; 7(5):841-9. PubMed ID: 22722786 [TBL] [Abstract][Full Text] [Related]
17. Quality-of-life outcomes for adjuvant chemotherapy in early-stage non-small-cell lung cancer: results from a randomized trial, JBR.10. Bezjak A; Lee CW; Ding K; Brundage M; Winton T; Graham B; Whitehead M; Johnson DH; Livingston RB; Seymour L; Shepherd FA J Clin Oncol; 2008 Nov; 26(31):5052-9. PubMed ID: 18809617 [TBL] [Abstract][Full Text] [Related]
18. [Chemotherapy in cancer of the lung]. Gütz S MMW Fortschr Med; 2006 Jun; 148(22):33-4. PubMed ID: 16821578 [TBL] [Abstract][Full Text] [Related]